Antares Pharma
Financial ratios & Valuation

Historical Multiples (2012 – 2021)

2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 TTM Median
Valuation Ratios
Price/Earnings ratio
-36.64-27.66-9.54-8.58-14.83-18.54-68-47012.0813.1222.39-14.83
Price/Sales ratio
18.5427.5112.663.886.915.696.977.694.533.305.185.69
Price/Book Value ratio
4.838.028.142.647.989.2511.3517.485.693.455.409.25
Price/Cash Flow ratio
-39.97-37.90-12.74-6.29-23.76-13.44-25.57-89.7431.8416.5831.95-23.76
Price/Free Cash Flow ratio
-29.96-31.29-10.48-5.08-17.87-12.74-24.32-73.48101.2520.2439.21-17.87
Price/Earnings Growth ratio
0.360.46-0.130.17-1.030.591.066.26-0.00-0.72-0.84-1.03
Dividend Yield
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
Profitability Indicator Ratios
Gross Profit Margin
57.82%55.39%57.59%57.38%44.81%49.61%51.12%59.24%57.82%62.88%61.51%44.81%
Operating Profit Margin
-50.72%-101.12%-132.49%-44.81%-46.18%-30.17%-6.45%0.80%9.10%33.84%31.46%-46.18%
Pretax Profit Margin
-50.61%-100.91%-132.54%-44.86%-46.41%-30.71%-10.25%-1.63%6.63%33.84%29.84%-46.41%
Net Profit Margin
-50.61%-99.45%-132.63%-45.24%-46.60%-30.71%-10.25%-1.63%37.56%25.15%23.14%-46.60%
Effective Tax Rate
N/A1.44%-0.07%-0.85%-0.41%-6.75%-4.00%-26.14%-466.48%25.66%22.44%-0.41%
Return on Assets
-11.96%-23.05%-51.11%-24.43%-36.69%-22.52%-7.38%-1.52%26.44%17.97%16.60%-36.69%
Return On Equity
-13.20%-28.99%-85.32%-30.81%-53.82%-49.90%-16.70%-3.71%47.18%26.33%27.20%-53.82%
Return on Capital Employed
-13.07%-28.73%-78.82%-30.20%-51.95%-28.07%-6.71%0.98%9.12%31.35%28.87%-51.95%
Liquidity Ratios
Current Ratio
9.784.442.213.922.273.522.623.342.00N/A3.072.27
Quick Ratio
9.503.911.973.582.002.942.202.851.712.542.792.00
Cash ratio
6.562.381.401.951.391.681.020.710.841.111.101.68
Days of Sales Outstanding
36.0318.3148.3463.5763.4179.52168.95127.62122.87164.67185.5863.41
Days of Inventory outstanding
38.44256.41190.34107.3867.47123.25133.35115.70105.3661.7059.92123.25
Operating Cycle
74.47274.72238.69170.95130.88202.78302.30243.32228.24226.38105.68202.78
Days of Payables Outstanding
109.82253.14327.1597.3199.8779.16130.8393.3193.6791.17102.7699.87
Cash Conversion Cycle
-35.3421.58-88.4673.6431.01123.62171.47150.00134.56135.2197.5931.01
Debt Ratios
Debt Ratio
0.090.20N/AN/AN/A0.330.280.310.190.090.310.33
Debt Equity Ratio
0.100.25N/AN/AN/A0.740.640.760.350.130.450.74
Long-term Debt to Capitalization
N/AN/AN/AN/AN/A0.420.360.420.170.100.110.42
Total Debt to Capitalization
N/AN/AN/AN/AN/A0.420.390.430.260.110.120.42
Interest Coverage Ratio
N/AN/AN/AN/AN/A-11.56-6.200.273.59N/A28.03N/A
Cash Flow to Debt Ratio
N/AN/AN/AN/AN/A-0.92-0.68-0.250.501.521.161.16
Company Equity Multiplier
1.101.251.661.261.462.212.262.431.781.461.452.21
Cash Flow Ratios
Operating Cash Flow / Sales Ratio
-0.46-0.72-0.99-0.61-0.29-0.42-0.27-0.080.140.190.16-0.29
Free Cash Flow / Operating Cash Flow Ratio
1.331.211.211.231.321.051.051.220.310.810.811.05
Cash Flow Coverage Ratio
N/AN/AN/AN/AN/A-0.92-0.68-0.250.501.521.161.16
Short Term Coverage Ratio
N/AN/AN/AN/AN/AN/A-5.69-8.491.228.6911.73N/A
Dividend Payout Ratio
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/AN/A